Squarepoint
UTMD icon

Squarepoint’s Utah Medical Products UTMD Stock Holding History

Squarepoint’s Portfolio UTMD Stock Details UTMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-9,398
Closed -$668K – 4686
2024
Q1 		$668K Buy
+9,398
New +$705K ﹤0.01% 2858
2023
Q3 		– Sell
-3,226
Closed -$301K – 4274
2023
Q2 		$301K Buy
+3,226
New +$304K ﹤0.01% 2973
2021
Q2 		– Sell
-2,714
Closed -$235K – 3722
2021
Q1 		$235K Buy
+2,714
New +$239K ﹤0.01% 2594
2020
Q1 		– Sell
-3,143
Closed -$339K – 2548
2019
Q4 		$339K Sell
3,143
-4,829
-61% -$489K ﹤0.01% 1977
2019
Q3 		$764K Buy
7,972
+5,472
+219% +$509K 0.01% 1401
2019
Q2 		$239K Buy
+2,500
New +$210K ﹤0.01% 2035

Other funds holding UTMD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

Squarepoint's UTMD Position: Q2 2024 in Review

Squarepoint sold out of Utah Medical Products (UTMD) in Q2 2024, closing a stake of 9,398 shares — an estimated $668K sold.

Squarepoint first reported a position in UTMD in Q2 2019 and held it in 6 quarters. The position peaked at $764K in Q3 2019. 100 funds tracked by Wall St. Rank hold UTMD as of Q2 2024.

  • Squarepoint reported no remaining Utah Medical Products position as of Q2 2024 after selling out during the quarter.
  • Squarepoint sold 9,398 Utah Medical Products shares in Q2 2024, an estimated $668K.
  • Squarepoint first reported a position in Utah Medical Products in Q2 2019 and held it in 6 quarters.
  • Squarepoint's Utah Medical Products position peaked at $764K in Q3 2019.
  • 100 funds tracked by Wall St. Rank held Utah Medical Products as of Q2 2024.

Based on Squarepoint's 13F filing for Q2 2024, filed 14 Aug 2024.